Database

Time Span

Search Strategy

The Cochrane Hepato‐Biliary Group Controlled Trials Register

Date will be given at review stage.

(((bile duct OR endobiliary) AND prosthes*) OR (endoscopic retrograde cholangiopancreatograph* OR ERCP) OR (stent* OR SEMS)) AND (((biliary enteric OR bile duct) AND bypass*) OR choledochostom* OR cholecystojejunostom* OR choledochojejunostom* OR choledochoduodenostom*) AND (malignant distal bile duct obstruction OR cholestasis OR (bile duct AND (adenoma* OR neoplasm*)))

Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library

Latest issue.

#1 MeSH descriptor: [Cholestasis] explode all trees

#2 MeSH descriptor: [Adenoma, Bile Duct] explode all trees

#3 MeSH descriptor: [Bile Duct Neoplasms] explode all trees

#4 'malignant distal bile duct obstruction' or cholestasis or ('bile duct' and (adenoma* or neoplasm*))

#5 #1 or #2 or #3 or #4

#6 MeSH descriptor: [Cholangiopancreatography, Endoscopic Retrograde] explode all trees

#7 MeSH descriptor: [Stents] explode all trees

#8 (('bile duct' or endobiliary) and prosthes*) or ('endoscopic retrograde cholangiopancreatograph*' or ERCP) or (stent* or SEMS)

#9 #6 or #7 or #8

#10 MeSH descriptor: [Choledochostomy] explode all trees

#11 (('biliary enteric' or 'bile duct') and bypass*) or choledochostom* or cholecystojejunostom* or choledochojejunostom* or choledochoduodenostom*

#12 #10 OR #11

#13 #5 and #9 and #12

MEDLINE Ovid

1946 to the date of search.

1. exp Cholestasis/

2. exp Adenoma, Bile Duct/

3. exp Bile Duct Neoplasms/

4. ('malignant distal bile duct obstruction' or cholestasis or ('bile duct' and (adenoma* or neoplasm*))).mp. [mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]

5. 1 or 2 or 3 or 4

6. exp Cholangiopancreatography, Endoscopic Retrograde/

7. exp Stents/

8 ((('bile duct' or endobiliary) and prosthes*) or ('endoscopic retrograde cholangiopancreatograph*' or ERCP) or (stent* or SEMS)).mp. [mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]

9. 6 or 7 or 8

10. exp Choledochostomy/

11. ((('biliary enteric' or 'bile duct') and bypass*) or choledochostom* or cholecystojejunostom* or choledochojejunostom* or choledochoduodenostom*).mp. [mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]

12. 10 or 11

13. 5 and 9 and 12

14. (random* or blind* or placebo* or meta‐analys*).mp. [mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]

15. 13 and 14

Embase Ovid

1974 to the date of search.

1. exp cholestasis/

2. bile duct tumor/

3. (distal bile duct obstruction' or cholestasis or ('bile duct' and (adenoma* or neoplasm*))).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]

4. 1 or 2 or 3

5. exp endoscopic retrograde cholangiopancreatography/

6. exp stent/

7. ((('bile duct' or endobiliary) and prosthes*) or ('endoscopic retrograde cholangiopancreatograph*' or ERCP) or (stent* or SEMS)).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]

8. 5 or 6 or 7

9. exp bile duct bypass/

10. ((('biliary enteric' or 'bile duct') and bypass*) or choledochostom* or cholecystojejunostom* or choledochojejunostom* or choledochoduodenostom*).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]

11. 9 or 10

12. 4 or 8 or 11

13. (random* or blind* or placebo* or meta‐analys*).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword]

14. 12 and 13

LILACS

1982 to the date of the search.

tw:("Malignant bile duct obstruction" OR (Bile duct AND (adenoma OR neoplasm) OR "ERCP" OR "endoscopic retrograde cholangiopancreatography" OR ((bile duct) AND stent) OR ((bile duct) AND bypass OR choledochostomy OR cholecystojejunostomy OR choledochoduodenostomy)) AND (Randomized controlled trial OR Controlled clinical trial OR Multicenter study OR Double‐blind or Random allocation))

Science Citation Index Expanded (Web of Science)

1900 to the date of search.

#1 TS=('malignant distal bile duct obstruction' OR cholestasis OR ('bile duct' AND (adenoma* OR neoplasm*)))

#2 TS=((('biliary enteric' OR 'bile duct') AND bypass*) OR choledochostom* OR cholecystojejunostom* OR choledochojejunostom* OR choledochoduodenostom*)

#3 TS=((('bile duct' OR endobiliary) AND prosthes*) OR ('endoscopic retrograde cholangiopancreatograph*' OR ERCP) OR (stent* OR SEMS))

#4 #1 AND #2 AND #3

#5 TS=(random* or blind* or placebo* or meta‐analys*)

#6 #4 AND #5